STENGONE CARMINE N.

PrivateCIK: 1861519
Location

SAN DIEGO, CA

STENGONE CARMINE N. (CEO and President) sold 32.2% of their position (7.10K shares) of CONTINEUM THERAPEUTICS, INC. on the open market

Open‑market sale worth $113.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderSTENGONE CARMINE N.CIK 1861519
DirectorOfficer· CEO and President
Since Feb 2026
-7.10K
Net shares
Net seller
$113.7K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
7.10K acquired · 14.20K disposed
Non-Derivative Transactions4

Class A Common Stock

Direct
M · Option Exercise

Shares

+4.40K

Price / share

$1.26

Trade value

$5.54K

% of position

29.4%
2/24/2026
14.95K19.35K

Class A Common Stock

Direct
S · Sale

Shares

4.40K

Price / share

$16.02

Trade value

$70.49K

% of position

22.7%
2/24/2026
19.35K14.95K

Class A Common Stock

Direct
M · Option Exercise

Shares

+2.70K

Price / share

$1.26

Trade value

$3.40K

% of position

18.1%
2/25/2026
14.95K17.65K

Class A Common Stock

Direct
S · Sale

Shares

2.70K

Price / share

$16.02

Trade value

$43.24K

% of position

15.3%
2/25/2026
17.65K14.95K
Total

Net shares

+0.00

Net value

-$104.78K

Derivative Transactions2

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Class A Common Stock

4.40K shares

Shares

4.40K

Strike price

1.26

Held after

123.62K

Exercisable

2/24/2026

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Class A Common Stock

2.70K shares

Shares

2.70K

Strike price

1.26

Held after

120.92K

Exercisable

2/25/2026
STENGONE CARMINE N. — Insider Transaction (Form 4) Filed Feb 26, 2026 | Finecho